Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845687 · ClinicalTrials.gov registry record
Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 209
- Enrollment target
NCT02845687: Clinical Trial study, sponsored by Duke University.
NCT02845687 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02845687 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 209 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operations. Primarily, this study will assess the financial sustainability and the cost-effectiveness of the program.
Primary Outcome
Biochemically confirmed 30-day continuous abstinence. Abstinence is determined by a participant both reporting not smoking in the past 30 days AND a result of \< 7 ppm in carbon monoxide breath testing. If the participant does not meet both criteria, they are not considered abstinent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2016-08-16 |
| Est. Completion | 2018-05-29 |
Why NCT02845687 stopped before completion
NCT02845687 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02845687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02845687 about?
NCT02845687 is a clinical study titled "Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program". The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operatio...
What is the current status of trial NCT02845687?
This trial is currently terminated. The enrollment target is 209 participants. The study started on 2016-08-16. Estimated completion is 2018-05-29.
Who is sponsoring clinical trial NCT02845687?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI